Dr. Atul Varadhachary is Managing Partner at Fannin Innovation Studio, Houston’s most active life sciences development group. Fannin has developed an approach to successfully in-license and develop technologies from academic institutions in a city outside major biotech hubs (http://goo.gl/cFyPky) with recognition including the SBIR’s “Tibbetts Award”. Fannin’s fifteen active technologies are split evenly between therapeutics and medical devices.
Before Fannin, Atul was President of U.S. Operations at Reliance Life Sciences, part of the Reliance Group, India’s largest private company. Atul served for nine years as President & COO of Agennix, Inc. where he led advancement of Agennix’s lead molecule from preclinical studies into pivotal Phase 3 human studies and helped lead a successful sale of the company. Atul served as a Senior Engagement Manager in the Houston office of McKinsey & Co. from 1994-2001.
Atul serves as an Adjunct Professor at Rice University, Baylor College of Medicine and the UT School of Public Health and is on several company and community Boards including BioHouston.
Atul received his medical training at the University of Bombay and a Ph.D. in Physiology from the Johns Hopkins School of Medicine in Baltimore, followed by a postdoctoral fellowship in Biological Chemistry, also at Johns Hopkins.